circ_0001006 Promotes Immune Escape in Non-small Cell Lung Cancer by Regulating the miR-320a/PD-L1 Axis

被引:1
作者
Geng, Zhenying [1 ]
Zhang, Guoqing [2 ]
机构
[1] Chinese Acad Sci, Zhongguancun Hosp, Dept Oncol, Beijing 100089, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, 8 East St, Beijing 100039, Peoples R China
关键词
circ_0001006; miR-320a; NSCLC; PD-L1; Progression; PD-L1; EXPRESSION; ADENOCARCINOMA; METASTASIS;
D O I
10.22034/iji.2025.102661.2792
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Circular RNAs are involved in the tumorigenesis of various tumors, including Non-small cell lung cancer (NSCLC). Objective: To investigate the expression of circ_0001006 in patients with NSCLC and its role in tumorigenesis and immune escape. Methods: A total of 115 patients with NSCLC were enrolled in the study. The expression of circ_0001006 and PD-L1 mRNA were detected using RT-qPCR. Cell proliferation activity, cell migration and invasion abilities were measured using the CCK-8 assay and Transwell chambers assay. Coculture of NSCLC cells with CD8 cytotoxic T cells was conducted to measure the levels of INF-gamma, TNF-alpha, IL-2, and lactate dehydrogenase release in culture supernatants. Bioinformatic analysis was used to predict the target relevance among circ_0001006, miR-320a, and PD-L1. Results: The circ_0001006 and PD-L1 mRNA levels were elevated in NSCLC tissues and cells. Patients with high levels of circ_0001006 had a shorter overall survival rate. Inhibiting circ_0001006 reduced the proliferation, migration, and invasion of NSCLC cells, while increasing PD-L1 partially counteracting the inhibitory effects of si-circ_0001006. The co-culture system of NSCLC and CD8+ T cell was found to reduce the viability of activated CD8+ T cell when circ_0001006 is present. Knocking down circ_0001006 in co- culture cells led to an increase in the expression of INF-gamma, TNF-alpha, and IL-2. The ability of si-circ_0001006 to enhance the activation of CD8+ T cells was diminished when PD-L1 was overexpressed. Conclusion: circ_0001006 may serve as a potential prognostic predictor and therapeutic target for NSCLC. Additionally, it offers insight into a novel regulatory mechanism of circ_0001006.
引用
收藏
页数:12
相关论文
共 50 条
[21]   Current Immunotherapeutic Strategies Targeting the PD-1/PD-L1 Axis in Non-Small Cell Lung Cancer with Oncogenic Driver Mutations [J].
Tanaka, Ichidai ;
Morise, Masahiro .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
[22]   CircFOXK2 enhances tumorigenesis and immune evasion in non-small cell lung cancer by miR-485-5p/PD-L1 axis [J].
Zhang, Nan ;
Fan, Jian ;
Deng, Zhiping .
ANTI-CANCER DRUGS, 2022, 33 (05) :437-447
[23]   Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer [J].
Li, Jingjing ;
Xu, Jinhua ;
Wu, Guofeng ;
Ren, Yajun ;
Wang, Xue ;
Zhang, Qianyun .
CHEMOTHERAPY, 2022, 67 (04) :223-233
[24]   CircENTPD7 affects the immune escape of non-small cell lung cancer cells by modulating the IGF2BP2/PD-L1 axis [J].
Yu, Hongwei ;
Zhang, Yibin ;
Yang, Rufei ;
Xie, Changbin ;
Liao, Zhiwei ;
Zhou, Tongchong .
ONCOLOGY LETTERS, 2025, 29 (03)
[25]   Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint [J].
Lei, Jie ;
Zhu, Jianfei ;
Hui, Bengang ;
Jia, Chenghui ;
Yan, Xiaolong ;
Jiang, Tao ;
Wang, Xiaoping .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (01) :101-124
[26]   Exosomal PD-L1 in non-small cell lung Cancer: Implications for immune evasion and resistance to immunotherapy [J].
Tarin, Mojtaba ;
Oryani, Mahsa Akbari ;
Javid, Hossein ;
Karimi-Shahri, Mehdi .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 155
[27]   Challenges of PD-L1 testing in non-small cell lung cancer and beyond [J].
Wang, Minyu ;
Wang, Sen ;
Trapani, Joseph A. ;
Neeson, Paul J. .
JOURNAL OF THORACIC DISEASE, 2020, 12 (08) :4541-4548
[28]   Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC) [J].
Papavassiliou, Kostas A. A. ;
Marinos, Georgios ;
Papavassiliou, Athanasios G. G. .
CELLS, 2023, 12 (06)
[29]   Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer [J].
He, Jiabei ;
Hu, Ying ;
Hu, Mingming ;
Li, Baolan .
SCIENTIFIC REPORTS, 2015, 5
[30]   CircDENND2D Inhibits PD-L1-Mediated Non-Small Cell Lung Cancer Metastasis and Immune Escape by Regulating miR-130b-3p/STK11 Axis [J].
Chen, Yongxing ;
Chen, Xianshan ;
Li, Zhao ;
Zhu, Yike ;
Liu, Fujin ;
Cai, Junhong .
BIOCHEMICAL GENETICS, 2023, 61 (06) :2691-2709